Sanolla is a pioneering brand at the forefront of primary care diagnosis solutions, offering groundbreaking technology for early exacerbation detection of chronic cardiopulmonary diseases using infrasound and AI. Their innovative products, such as the VoqX stethoscope and PyXy clinic at home device, provide immediate and accurate assessments for conditions like heart failure, COPD, and asthma. These AI-powered solutions not only save time and money but also reduce the risk of exposure to infections by minimizing unnecessary in-clinic visits.

Sanolla's commitment to enhancing patient care is evident in their cutting-edge devices that analyze the body's full spectrum of sounds, including previously inaccessible infrasounds, transforming the way healthcare professionals diagnose and monitor patients. With FDA clearance and a strong focus on improving patient outcomes, Sanolla is shaping the future of patient care with their innovative technology and vision for a healthier world